Companies and investors in the pharmaceutical sector have been concerned about the possible effects of the Inflation Reduction Act in recent months.…

When reinsurers meet in Monte Carlo, fund manager and analyst Moritz Rehmann listens very carefully. Because the discussions provide important…

Companies are investing astronomical sums in their AI capacities. But are they making money? Or who is profiting from the current hype? An analysis by…

In an interview for the ARD format Update Wirtschaft, DJE analyst Sebastian Hofbeck describes current developments in the pharmaceutical sector…

The global mining sector has recently been back in the focus of many investors due to a major takeover attempt. You can find out more about the sector…

Opportunities and risks in the healthcare sector

Diabetes and obesity continue to dominate the healthcare sector. A recent study by Goldman Sachs…